AstraZeneca establishes new world-class functional genomics laboratory with Medical Research Council and the Milner Therapeutics Institute at the University of Cambridge to accelerate drug discovery and further UK’s global genomics leadership
Facility will support discovery of new medicines and diagnostics for chronic diseases by applying advanced biological and technological tools, including CRISPR gene editing.
